Home / Centerstage / 2014 / april / Week 3 /
Eli Lilly and Co. announces its acquisition of Novartis AG's animal-health business for $5.4 billion. This move positions Lilly's Elanco unit as the second-largest global animal-health company, trailing only Zoetis Inc. The deal reflects Lilly's investment in the growing demand for animal drugs and vaccines worldwide.
Monday, 21 April, 2014